FDA-TRACK: What's New
FDA-TRACK is committed to providing you with the latest available performance data from across the Agency. Check the What's New page often to see the latest updates. Sign-up to receive the FDA-TRACK Newsletter and have updates delivered right to your inbox.
FDA-TRACK FY22 Data Updates
FDA-TRACK has released FY22 performance data. Review the FDA-TRACK product dashboards to see what FDA has accomplished towards its strategic goals in FY22.
New NCTR Key Projects
The National Center for Toxicological Research has developed two new Key Projects: 'Assessing the Effects of Methadone or Buprenorphine and their Combined Use with Cannabinoids on Human Neural Stem Cells' and 'Investigating Early Signs of Sex-Difference in Adverse Drugs Effects to Better Protect Women’s Health'.